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Abstract
Background: Atrial electromechanical delay (AEMD) that reflects delayed conduction may 
show us the clinical reflection of pathological changes in the atria. The main objective of the 
present study is to investigate AEMD in patients who had previous rheumatic carditis but 
without hemodynamically significant valvular disease.
Methods: A total of 40 patients, previously diagnosed as rheumatic carditis but without sig-
nificant valvular stenosis/regurgitation and atrial enlargement; and 39 age- and-sex matched 
controls were enrolled for the present study. Parameters of AEMD (lateral mitral annulus elec-
tromechanical delay, septal mitral annulus electromechanical delay and lateral tricuspid an-
nulus electromechanical delay) were measured with tissue Doppler echocardiography and left 
intra-atrial and inter-atrial conduction times were calculated accordingly. A 24 h ambulatory 
Holter monitoring was used in both groups to detect atrial fibrillation episodes and quantify 
atrial extrasystoles.
Results: Parameters of AEMD, including left intra-atrial and inter-atrial conduction times of 
subjects in the study group were longer compared to the control group (23.7 ± 7.0 vs. 18.3 ± 6.2).
Conclusions: Increased AEMD is observed in patients with previous rheumatic carditis 
and no significant valvular stenosis/regurgitation and atrial enlargement, which may partly 
explain the increased incidence of atrial fibrillation observed in these patients. (Cardiol J 2015; 
22, 6: 683–690)
Key words: atrial electromechanical conduction delay, hemodynamically  
insignificant rheumatic heart disease, echocardiography
Introduction
Rheumatic valvular disease (RVD) still has an im-
portant place among heart diseases in less developed 
and developing societies. Approximately 15 million 
people are estimated to be suffering from rheumatic 
valvular disease worldwide [1, 2]. In regions with a high 
prevalence of acute rheumatic fever (ARF), echocar-
diographic screening for the detection of RVD is still 
recommended by the World Health Organization [3].
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The incidence of atrial fibrillation (AF) is 
increased in patients with RVD and it can be as 
high as 70% when accompanying mitral regurgi-
tation, mitral stenosis or tricuspid regurgitation 
are present [4]. The basic mechanism of valvular-
originated AF is atrial remodeling, which in-
volves histo-pathological and electrophysiological 
changes induced by the increase in atrial volume 
and pressure. Still, an increased incidence of AF 
is observed in patients with previous rheumatic 
carditis (RC) without significant valve stenosis/ 
/regurgitation and pressure/volume overload. The 
exact cause for this increase is not known, but it 
was previously suggested that chronic atrial inflam-
mation accompanying previous rheumatic fever 
(RF) could create a substrate for AF [5, 6].
Delayed inter- and intra-atrial conduction time 
(ACT) reflects heterogeneity of atrial conductivity, 
which is a known risk factor for AF. The predictive 
value of ACTs for the development of AF, whether 
measured invasively with electrophysiologic study 
or noninvasively with echocardiography, has been 
established in previous studies [7, 8]. The prolon-
gation of ACT is linked to a variety of mechanisms, 
including atrial dilatation and remodeling, chronic 
inflammation within the atrial myocardium, and 
atrial fibrosis. Therefore, ACT prolongation could 
act as an intermediary mechanism linking RF- 
-related changes in atrium (including chronic inflam-
mation and fibrosis) with the development of AF.
In the present study, we aimed to investigate 
the duration of ACT in RVD patients without sig-
nificant valvular stenosis/regurgitation or atrial 
enlargement and to compare these findings with 
healthy controls. In addition, we investigated the 
value of ACT duration as a predictor for develop-
ment of AF in patients with previous RF.
Methods
Study design and patient selection
Patients who admitted to institutional out-
patient clinic between January 2010 and January 
2012 with a previous diagnosis of RF were en-
rolled in the present study. The inclusion criteria 
included 1) At least one previous documented RF 
episode in which the diagnosis was established 
according to Jones or Modified Jones criteria and 
documented signs for cardiac involvement during 
this episode (new valvular murmur, signs of heart 
failure, etc.) or 2) Rheumatic valve involvement 
at follow-up echocardiograms in patients with 
a previous documented RF episode. All these 
patients were using or had previously used depot 
penicillin monthly for secondary prophylaxis for 
a long time. All systemic diseases or disorders and 
structural cardiac pathologies that could have af-
fected electromechanical conduction delay times 
were evaluated meticulously in order to obtain 
more objective results. Patients under 18 years of 
age, those with a history of previous myocarditis 
and/or pericarditis not attributable to ARF episode, 
right and/or left atrial (LA) enlargement during 
screening echocardiography, moderate or severe 
mitral, tricuspid, or aortic valve insufficiency, mild, 
moderate, or severe stenosis in any one of mitral, 
aortic, tricuspid and pulmonary valves, those with 
congenital cardiac defects (including those with 
a previous operation for congenital heart disease), 
coronary artery disease, previous episode of unsta-
ble angina/myocardial infarction, previous coronary 
revascularization, any type of cardiomyopathy, 
systemic/pulmonary hypertension, diabetes mel-
litus, any degree of diastolic dysfunction during 
screening echocardiography, inadequate image 
quality during screening echocardiography, severe 
systemic disease (chronic kidney disease, chronic 
liver disease, autoimmune disease, anemia, hy-
perthyroidism or hypothyroidism, malignancy 
and electrolyte disorders) that could have led to 
diastolic dysfunction or that could have affected 
electromechanical conduction delay times were 
excluded from the study. In addition, patients who 
underwent ablation therapy due to tachyarrhyth-
mia, were taking antiarrhythmic medications, had 
a resting pulse rate higher than 90 bpm or lower than 
60 bpm were excluded from the study. A screening 
echocardiogram was commenced prior to enrol-
ment to check the presence of exclusion criteria. 
A total of 76 subjects with previous RC history 
were evaluated. Thirty-six subjects were excluded 
because of having one or more exclusion criteria 
that we mentioned above and finally, 40 patients 
who fulfilled all criteria were enrolled. Thirty-nine 
asymptomatic healthy volunteers without medi-
cal history (of any systemic disease), in whom no 
cardiovascular pathology was detected as a result 
of treadmill exercise testing, electrocardiographic 
(ECG), echocardiographic, laboratory and clinical 
assessment, were included in the control group. 
None of these people had a history of RC and they 
had normal valvular structure echocardiographi-
cally. Non-invasive diagnostic methods were per-
formed to obtain and exclude subclinical or hidden 
disorders in these asymptomatic patients. Because 
minimal mitral and/or aortic regurgitation present 
in the both groups does not lead to a structural 
and functional alteration in the LA, these minimal 
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valvular pathologies will not, in theory, have an 
independent effect on atrial electromechanical 
delay (EMD) times. All participants included in 
the study were examined in the echocardiography 
laboratory of Dr Siyami Ersek Hospital between 
January 2010 and January 2012.
Clinical and demographic information was col-
lected from all subjects at the time of enrolment. 
A baseline ECG and laboratory tests, including 
complete blood count and blood chemistry, were 
obtained, with the blood withdrawn after overnight 
fasting for the latter. The p wave duration (PWD) 
was measured from lead D II and an average of 
3 measurements from consecutive beats was ac-
cepted as PWD. A PWD of more than 120 ms in 
the absence of LA enlargement (LA volume index 
[LAVI] < 20 mL/m2) was accepted as an interatrial 
block (IAB). To investigate the presence of atrial 
arrhythmias, including AF, a Holter device was 
used to digitally store 3-channel ECG for 24-h. 
These ECG recordings were analyzed offline using 
a computer terminal and compatible software to 
count the total number of atrial extrasystoles and 
other specific arrhythmias. All procedures were 
performed using standardized techniques.
This study was carried out according to the 
Principles of the Declaration of Helsinki, and writ-
ten informed consent was obtained from all the pa-
tients. The study was approved by the institutional 
Ethics Committee.
Echocardiographic measurements
A standard transthoracic echocardiographic 
examination was performed on each patient by 
a single experienced cardiologist. Transthoracic 
echocardiographic images were obtained from the 
parasternal and apical 4, 3 and 2 chamber views 
with 2.5–3.5 MHz phased-array transducer by 
using GE Vivid 7 machine (GE Vivid 7, GE Health-
care, Piscataway, NJ, USA). The examination was 
performed while the patient was lying down in 
the left lateral and supine positions; each patient 
was evaluated by M-mode, B-mode, color Doppler 
and tissue Doppler echocardiography. Single-lead 
ECG recordings were taken continuously through-
out the examination. Echocardiography and ECG 
signals were recorded in harmony in order to ob-
tain more objective measurements and not to have 
measurement errors. All measurements were 
made with the same probe in the same echocardi-
ography device by a single experienced cardiolo-
gist. Left ventricular end-diastolic, end-systolic 
diameters and left atrium end-systolic diameters 
were measured with M-mode echocardiography 
from parasternal long axis view. Left atrial area 
which was measured in order to calculate the 
left atrial volume was recorded as the average 
of the widest area measured at 3 consecutive 
beats. Left atrial volume was calculated by us-
ing biplane Simpson method as recommended by 
the American Society of Echocardiography. LAVI 
was calculated in terms of mL/m2 by dividing left 
atrial volume to body surface area. Mitral inflow 
velocity was assessed by pulsed-wave Doppler 
placed at the tip of the mitral valve from the apical 
4-chamber window. Diastolic early (E) and late (A) 
peak flows were measured. Tissue Doppler echo-
cardiography was performed by adjusting spectral 
pulsed Doppler signal filters until the Nyquist 
limit was 15–20 cm/s, with 3.5–4.0 MHz frequency 
transducer, by using the minimal optimal gain. 
Sweep speed of the monitor was set 100 mm/s so 
that the spectral images of myocardial velocities 
were optimal. Tissue Doppler spectral views were 
obtained by placing pulsed wave (PW) tissue Dop-
pler cursor in the apical 4-chamber view window 
to the left ventricular mitral lateral and septal 
annulus and right ventricular tricuspid lateral 
annulus, respectively. PW cursor was aligned as 
parallel as possible to the myocardial segment of 
interest to ensure the optimal angle of imaging. 
Myocardial peak systolic (S), early (E’) and late 
(A’) diastolic peak velocities were obtained from 
these regions. Atrial EMD delay was defined as 
the time (PA’) elapsed from the beginning of the 
P wave in lead D II in the ECG to the beginning 
of the A’ wave in tissue Doppler trace for lateral 
mitral annulus (PA’ lateral EMD), septal mitral 
annulus (PA’ septal EMD) and lateral tricuspid an-
nulus (PA’ tricuspid EMD) in terms of millisecond. 
A flow diagram for the study is provided in Figure 1. 
Figure 1. Measurement of atrial electromechanical con-
duction delay via tissue Doppler echocardiography.
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Values were averaged over 3 consecutive beats. 
To obtain a perfect synchronization all measure-
ments of every patient were remade and the same 
results were obtained. The difference between PA’ 
lateral EMD and PA’ tricuspid EMD was defined 
as inter-atrial conduction time, and the difference 
between PA’ lateral EMD and PA’ septum EMD 
was defined as left intra-atrial conduction time. 
For all measurements, recommendations from the 
American Society of Echocardiography were used 
where possible.
Statistical analysis
SPSS 15.0 software was used for statisti-
cal analysis of the data obtained from the study. 
Continuous variables were presented as mean 
± standard deviation while categorical data were 
given as percentage of total. One-way Kolmogorov-
Smirnov test was used to determine the pattern of 
distribution for continuous variables. For continu-
ous variables with a normal distribution, Student’s 
t-test was used to compare groups, while Mann-
Whitney U test was used when the distribution 
was not normal. For categorical variables, c2 and 
Fisher’s exact tests were used as appropriate. 
Correlations between continuous variables were 
analyzed with Pearson or Spearman correlation 
tests, with the latter used when the distribution 
of one of the parameters within the group was not 
normal. For all comparisons, a p value lower than 
0.05 was accepted as significant.
Results
Demographic, and clinical data regarding the 
study and control groups are given in Table 1. 
There were no statistically significant differences 
between groups regarding the demographic or 
clinical variables. PWD was significantly higher in 
the study group (90.47 ± 10.31 vs. 71.48 ± 12.44, 
p < 0.001), but no subjects in both groups had 
a PWD > 120 ms and therefore had no IAB. Echo-
cardiographic variables, such as left ventricular 
dimensions, wall thickness, ejection fraction, left 
atrial volume, LAVI, E, A, E’, A’ and E/E’ were also 
similar between two groups. There was a positive 
correlation between LAVI and age of subjects 
(r = 0.336, p < 0.01). Aortic valve involvement 
was present in 42% (n = 16) of cases in the study 
group. No correlation was found between LAVI 
and the number of  affected valves (r = 0.11, 
p = 0.32) (Table 2).
Indices of atrial EMD, including PA’ lateral 
EMD, PA’ septal EMD and PA’ tricuspid EMD; left 
intra-and inter-atrial conduction times, measured 
by echocardiography, of the patients enrolled in 
the study are presented in Table 3. Atrial EMD, 
left intra- and inter-atrial conduction times were 
Table 1. Baseline demographics, hemodynamic parameters, hemoglobin, thyroid stimulating hormone 
levels and atrial extrasystole (AES) incidence in 24-h rhythm Holter recordings of the 77 study subjects 
(patient and control group), categorized with respect to the center of origin.
Variables Patient group  
(mean ± SD)
Control group  
(mean ± SD)
P
Patients 40 39 –
Age [year] 34.8 ± 9.1 31.3 ± 10.1 0.13
Male 18.4% 20.2% 0.15
Body surface area [m2] 1.69 ± 0.15 1.69 ± 0.21 0.88
Heart rate [bpm] 74.3 ± 9.4 76 ± 6.7 0.3
Systolic blood pressure [mm Hg] 103.5 ± 9.4 105.6 ± 8.1 0.29
Diastolic blood pressure [mm Hg] 66.2 ± 9 65.9 ± 8.1 0.88
Hemoglobin [mg/dL] 13.2 ± 1.3 13.7 ± 1.2 0.13
TSH [IU/mL] 2.3 ± 1.0 2.4 ± 0.96 0.13
AES in 24-h rhythm Holter ECG 357.63 ± 2,088.30 0.79 ± 1.13 < 0.01
P wave duration [ms] 90.47 ± 10.31 71.48 ± 12.44 < 0.001
Interatrial block [%] 0 0 1
AES in 24-h rhythm Holter ECG (after exclusion of outliers) 18.89 ± 26.71 0.79 ± 1.13 < 0.01
SD — standard deviation; TSH — thyroid stimulating hormone; ECG — electrocardiography
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Table 2. Two dimensional echocardiographic parameters of study subjects.
Variables Patient group (mean ± SD) Control group (mean ± SD) P
LVEDD [mm] 44.5 ± 1.6 44.9 ± 2.2 0.37
LVESD [mm] 25.4 ± 2.0 25.9 ± 2.2 0.31
IVS [mm] 8.07 ± 0.88 8.1 ± 0.99 0.91
PW [mm] 7.8 ± 0.75 7.7 ± 0.78 0.57
EF [%] 65.6 ± 3.1 65.1 ± 2.5 0.47
LAVol [mL] 37.4 ± 8.4 35.2 ± 6.5 0.2
LAVI [mL/m2] 22.3 ± 3.6 21.5 ± 3.4 0.3
E [m/s] 0.95 ± 0.19 0.95 ± 0.18 0.98
A [m/s] 0.63 ± 0.14 0.61 ± 0.15 0.62
E’ [cm/s] 14.5 ± 2.5 14.8 ± 2.3 0.66
A’ [cm/s] 8.8 ± 2.5 8.9 ± 2.3 0.88
E/E’ 6.6 ± 1.5 6.5 ± 1.3 0.63 
SD — standard deviation; LVEDD — left ventricular end-diastolic dimension; LVESD — left ventricular end-systolic dimension; IVS — interven-
tricular septum; PW — posterior wall; EF — ejection fraction; LAVol — left atrial volume; LAVI — left atrial volume index
Table 3. Atrial electromechanical delay (EMD), left intra-atrial and inter-atrial conduction times of the 
study subjects.
Variables Patient group (mean ± SD) Control group (mean ± SD) P
PA’ lateral EMD [ms] 89.4 ± 10.8 68.6 ± 14.9 < 0.001
PA’ septal EMD [ms] 65.7 ± 9.1 50.2 ± 11.4 < 0.001
PA’ tricuspid EMD [ms] 50.74 ± 7.0 41.5 ± 9.0 < 0.001
Intra-atrial conduction 
time [ms]
23.7 ± 7.0 18.3 ± 6.2 < 0.001
Inter-atrial conduction 
time [ms]
38.7 ± 12.1 27.4 ± 8.2 < 0.001
SD — standard deviation; PA’ lateral EMD — lateral mitral annulus EMD; PA’ septal EMD — septal mitral annulus EMD; PA’ tricuspid EMD — 
lateral tricuspid annulus EMD
Figure 2. Box-plot representations for left intra-atrial 
conduction time in study and control groups. The dif-
ference between groups is statistically significant at 
0.001 level.
Figure 3. Box-plot representations for left inter-atrial 
conduction time in study and control groups. The dif-
ference between groups is statistically significant at 
0.001 level.
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prolonged in the study group compared to the 
healthy volunteers (p < 0.001) (Table 3, Figs. 2, 3). 
There was no significant correlation between LAVI 
and PA’ lateral EMD (r = 0.057, p = 0.614), PA’ 
septal EMD (r = 0.040, p = 0.724), PA’ tricuspid 
EMD (r = 0.099, p = 0.388), left intra-atrial con-
duction time (r = 0.062, p = 0.587) and inter-atrial 
conduction time (r = 0.11, p = 0.924). PWD had 
a significant, moderate-to-well correlation with 
both left intra-atrial (r = 0.51, p < 0.001 for the 
study group and r = 0.71, p < 0.001 for the con-
trol group) and inter-atrial (r = 0.72, p < 0.001 
for the study group and r = 0.73, p < 0.001 for 
the control groups) conduction times. The to-
tal count of atrial extrasystoles on 24 h Holter 
monitoring was significantly higher in the study 
group compared to the control group (357.63 ± 
± 2,088.30 vs. 0.79 ± 1.13, p < 0.001), and the 
statistical significance remained even when one pa-
tient with a high atrial extrasystole count (12,891) 
was excluded from the analysis (18.89 ± 26.71 vs. 
0.79 ± 1.13, p < 0.001). There was a significant cor-
relation between intra-atrial conduction time and 
atrial extrasystoles (AES) count in the study group 
(p = 0.025, r = 0.42), but the statistical significance 
was lost when one outlier patient was excluded 
from analysis (p = 0.21, r = 0.25). One episode of 
AF was observed in 1 patient in the study group.
Discussion
Humoral and cellular inflammation within the 
endocardium, myocardium, pericardium and valvular 
structures which is caused by an autoimmune re-
sponse, forms the basis of ARC. Following the acute 
episode, a chronic inflammatory reaction which is 
characterized by infiltration of target tissues by 
T cells and macrophages persist for years and even-
tually causes deformation of valvular structures, 
vacuolar degeneration within the atrial myocytes, 
interstitial fibrosis, and an increase in adipocytes [6]. 
Both the formation and the propagation of electri-
cal impulses are negatively affected by increased 
interstitial fibrosis and cellular degeneration. These 
changes within the atrium cause a decrease in the 
number of L-type calcium channels and reduced 
calcium influx that affects impulse generation and 
transmission. These changes are important elec-
trophysiological precursors for the development 
of AF, as shown with many pre-clinical and clinical 
studies [9–12]. In patients with pure rheumatoid 
mitral disease, subjects with AF had higher left atrial 
volumes than those in sinus rhythm, and the degree 
of underlying valvular pathology did not correlate 
with LA volume. In addition, all patients with AF had 
histopathological changes in atrial myocardium, such 
as vacuolar degeneration and interstitial fibrosis, 
while the same changes were observed in 56% of 
patients with normal sinus rhythm [5]. These find-
ings suggest that chronic inflammation per se plays 
a role for the development of AF, which is independent 
of underlying valvular pathology [6].
Indicators of electromechanical heterogene-
ity along the atria reflect the pathological changes 
within the atrium and also indicate an increased 
risk for AF development [1, 12]. Although the gold 
standard measure for atrial EMD is direct measure-
ment with an electrophysiological study (EPS), the 
invasive nature of this modality makes it impracti-
cal to be used to determine ACTs. Instead, tissue 
Doppler echocardiography allows noninvasive 
measurement of ACTs with an acceptable accuracy 
when compared to EPS [8]. Prolongation of ACTs 
is observed in patients with various conditions 
that pose an increased tendency to AF, such as 
paroxysmal AF, mitral stenosis or systemic scle-
rosis [13–15]. Left atrial dilatation is undoubtedly 
a major cause for this increase in ACTs. However, 
ACT prolongation can be observed even in the 
absence of LA dilatation, suggesting presence of 
additional factors. Patients with systemic inflamma-
tory diseases, such as systemic sclerosis or psoriasis 
vulgaris, have longer ACT duration and a tendency 
for AF development, suggesting a relationship 
between chronic inflammation and ACT [14, 15]. 
Present study also shows that ACT prolongation is 
not solely related to LA dilatation, and is probably 
related to atrial inflammation. Unfortunately, cohort 
duration of follow up is inadequate in present study 
to show prolonged ACT as a risk factor for AF in 
patients with hemodynamically insignificant rheu-
matic carditis. However, in order to be able to say 
that prolongation of ACTs we obtained in patients 
with minimal rheumatic carditis may predict the 
development of AF, certainly follow-up period for 
years is required. Therefore, these patients were 
put under long-term follow-up for AF development. 
Prolongation of PWD in the study group, as 
discussed later, further reinforces these findings. 
We hypothesize that chronic inflammation related 
to previous rheumatic involvement remains as the 
most plausible explanation for both findings, similar 
to systemic inflammatory diseases discussed before. 
Unfortunately, the duration of follow-up is inad-
equate in the present study to show that prolonged 
interatrial conduction time or PWD is a risk factor 
for AF in patients with previous RC but without 
significant valvulopathy and/or LA enlargement.
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Prolongation of PWD on surface ECG reflects 
abnormal interatrial conduction. A PWD dura-
tion of 120 ms of more in the presence of normal 
P wave axis is termed a first degree IAB, while the 
presence of a negative terminal deflection on in-
ferior leads in the presence of a PWD > 120 ms is 
termed a third degree IAB [16]. Both conditions 
are associated with an increased frequency of atrial 
tachyarrhythmias, including AF [17]. Although the 
frequency of IAB is closely related to the presence 
of LA enlargement, IAB can be seen in subjects 
with normal LA dimensions, and presence of IABs 
are related with abnormal LA function [16, 18]. In 
the present study, we found prolonged PWD in 
study group, albeit none of the subjects had IAB. 
This finding, taken together with the prolongation 
of interatrial conduction time and the good correla-
tion between PWD and interatrial conduction time 
— further supports the presence of conduction 
abnormalities in LA after RC, even in the absence 
of LA pressure or volume overload.
Atrial extrasystoles serve as a trigger for 
various supraventricular tachycardias, including 
AF [19]. Patients with increased number of AES on 
24-h monitoring have an increased risk for develop-
ing AF [20]. We observed in this present study that 
patients with hemodynamically insignificant RC 
have more AES compared to healthy volunteers 
(p < 0.01), and there is a tendency for more ACTs in 
those with more pronounced prolongation of intra-
atrial conduction time (p = 0.025, r = 0.42), but the 
significance is lost when one outlier is removed. We 
consider that this potential relationship between 
intra-atrial conduction time and AES frequency is 
particularly interesting considering the relation-
ship between AES count and AF development. 
However, a definite link could not be shown in this 
study and this topic deserves further research to 
ascertain whether ACT prolongation is also a risk 
factor for AES.
Although there is not any structural cardiac 
pathology in patients with lone AF, atrial volume 
is higher than the normal population and patho-
logic mitral regurgitation, albeit minimal, is more 
frequent [21]. In addition, there are cause unclear 
atrial signs of active and chronic inflammation 
in lone AF [22]. When we take into account that 
rheumatic valve disease may be asymptomatic and 
there is not any specific echocardiographic findings 
to RVD, likelihood of minimal RC, which triggers 
the inflammation in the atria in some patients with 
lone AF, is quite thought-provoking.
Limitations of this study
The main limitation of the present study is 
that this is a single center study and the size of 
the study population was small. Limited power of 
the present study does not allow evaluation of the 
relationship between ACT prolongation and AF in 
this patient cohort, although previous studies have 
established prolonged ACTs as a risk factor of AF. 
Therefore, further studies are needed to ascertain 
whether this prolongation translates into clini-
cally meaningful results. Inflammation remains the 
most plausible explanation for ACT prolongation 
in RC patients, but this study was not designed 
to investigate the cause of ACT prolongation and 
further research is needed to ascertain this point. 
Although RC patients have prolonged ACTs and 
more frequent AES on 24 h Holter, prolonged intra-
atrial conduction time may not be the cause for this 
increase considering the possibility of collinearity. 
In addition, speckle tracking was not used to evalu-
ate atrial electromechanical conduction delay and 
we could not perform EPS to confirm the results 
because it was not ethically possible.
Conclusions
Patients with RC but without significant valve 
involvement have increased ACTs despite normal 
LA volumes. This increase in ACTs can explain the 
increased frequency of AF in patients with RC even 
when significant valve disease and LA pressure/ 
/volume overload is not present. More research is 
needed to ascertain whether this prolongation of 
ACTs could serve as a clinical tool to determine 
the risk of AF in this patient group.
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